MKLN1

MKLN1 encodes muskelin, an intracellular adaptor protein that integrates cytoskeletal, ubiquitin-ligase, and growth-signaling functions (PMID:10640805, PMID:41315365, PMID:38746323). Originally identified as a mediator of cell spreading and cytoskeletal responses to the extracellular matrix component thrombospondin-1 (PMID:10640805), muskelin is now established as a substrate and assembly factor of the CTLH E3 ubiquitin ligase: MKLN1 is required for the formation of CTLH-MKLN1 complexes (distinct from CTLH-WDR26 assemblies), and these complexes target UNG2 for degradation to support antibody diversification, since Mkln1-deficient mice show reduced somatic hypermutation and class switch recombination from UNG2 accumulation alongside altered germinal-center and developmental B-cell populations (PMID:40838616). When not degraded by the CTLH complex, MKLN1 accumulates at the lysosomal outer membrane together with ZMYND19, binds Raptor and RagA/C, and blocks a late step of mTORC1 activation by disrupting mTORC1 interaction with Rheb and with its substrates S6K and 4E-BP1, independently of the tuberous sclerosis complex—so CTLH-mediated degradation of MKLN1 tunes mTORC1 activity (PMID:41315365, PMID:38746323). Loss-of-function of MKLN1 via a splice variant causing exon skipping and frameshift produces lethal acrodermatitis, a genodermatosis with poor growth, immune deficiency, and skin lesions (PMID:29565995).

1. 1999 Medium

   Established the first functional identity of human muskelin by cloning the gene and linking it to cytoskeletal responses to the extracellular matrix.

   Evidence cDNA cloning, physical mapping, and FISH localization to chromosome 7q32

   PMID:10640805

   Open questions at the time

   • Cell-spreading/cytoskeletal function attributed from prior mouse work, not newly demonstrated here
   • No molecular partners or biochemical mechanism defined
   • No connection to ubiquitin ligase or mTORC1 functions
2. 2018 High

   Demonstrated that loss of functional MKLN1 causes disease, defining an in vivo requirement for the protein in growth, immunity, and skin integrity.

   Evidence GWAS, haplotype analysis, whole-genome sequencing, and RT-PCR confirmation of exon-4 skipping in affected vs. control dogs (lethal acrodermatitis)

   PMID:29565995

   Open questions at the time

   • Molecular mechanism connecting MKLN1 loss to the skin/immune phenotype not resolved
   • Did not identify MKLN1 protein partners or pathway
   • Phenotype defined in dogs; human disease relevance not addressed
3. 2024 High

   Defined a signaling mechanism: MKLN1 is a CTLH ligase substrate that, when stabilized, acts as a lysosomal negative regulator of mTORC1.

   Evidence Genome-wide CRISPR screen, MAEA knockout, reciprocal Co-IP (MKLN1/ZMYND19/Raptor/RagA/C), lysosomal fractionation, mTORC1 activity assays, and proteasome inhibition

   PMID:38746323 PMID:41315365

   Open questions at the time

   • Structural basis for how MKLN1/ZMYND19 occlude Rheb and substrate access not resolved
   • Physiological conditions that trigger MKLN1 stabilization vs. degradation not defined
   • Role of the ancestral thrombospondin/cytoskeletal function in this pathway unaddressed
4. 2025 High

   Established MKLN1 as an obligate assembly factor for a distinct CTLH-MKLN1 ligase that controls antibody diversification through UNG2 turnover.

   Evidence Mkln1-/- mice with flow cytometry of B-cell populations, somatic hypermutation and class switch recombination assays, and UNG2 protein-level measurement

   PMID:40838616

   Open questions at the time

   • Full substrate repertoire of CTLH-MKLN1 beyond UNG2 and FAM72A not enumerated
   • Molecular determinants distinguishing CTLH-MKLN1 from CTLH-WDR26 assemblies not defined
   • Link between this ligase function and the mTORC1-regulatory pool of MKLN1 not integrated

• How MKLN1's distinct roles—cytoskeletal/thrombospondin response, CTLH-MKLN1 ligase assembly, and lysosomal mTORC1 regulation—are coordinated within a cell remains unresolved.
• No structural model unifying its adaptor functions
• Conditions partitioning MKLN1 between ligase assembly and degradation unknown
• Mechanistic basis of the original cytoskeletal/thrombospondin role uncharacterized in the available corpus